Mouse ntESCs can be efficiently derived from telomerasedefective cells by SCNT 
In Brief
Sung et al. demonstrate in a mouse model that telomeres of telomerase haplo-insufficient cells can be elongated by somatic cell nuclear transfer. Moreover, ntESCs derived from Terc +/À cells exhibit pluripotency evidenced by generation of Terc +/À ntESC clone pups by tetraploid embryo complementation, the most stringent test of naive pluripotency.
SUMMARY
Haplo-insufficiency of telomerase genes in humans leads to telomere syndromes such as dyskeratosis congenital and idiopathic pulmonary fibrosis. Generation of pluripotent stem cells from telomerase haplo-insufficient donor cells would provide unique opportunities toward the realization of patient-specific stem cell therapies. Recently, pluripotent human embryonic stem cells (ntESCs) have been efficiently achieved by somatic cell nuclear transfer (SCNT). We tested the hypothesis that SCNT could effectively elongate shortening telomeres of telomerase haploinsufficient cells in the ntESCs with relevant mouse models. Indeed, telomeres of telomerase haploinsufficient (Terc +/À ) mouse cells are elongated in ntESCs. Moreover, ntESCs derived from Terc +/À cells exhibit naive pluripotency as evidenced by generation of Terc +/À ntESC clone pups by tetraploid embryo complementation, the most stringent test of naive pluripotency. These data suggest that SCNT could offer a powerful tool to reprogram telomeres and to discover the factors for robust restoration of telomeres and pluripotency of telomerase haplo-insufficient somatic cells.
INTRODUCTION
Mammalian telomere lengths are primarily regulated by telomerase, consisting of a reverse transcriptase protein (TERT), a RNA subunit (TERC), and stabilizing proteins including dyskerin, in a temporally and spatially dependent manner (Gü nes and Rudolph, 2013 ). Telomerase activity is high during early embryo development, but becomes undetectable in most adult cells in humans. Mutations of genes that encode telomerase components, TERT, TERC, or DKC1, cause premature aging and agerelated diseases, including aplastic anemia, dyskeratosis congenital, and idiopathic pulmonary fibrosis, collectively referred to as ''telomere syndromes'' to reflect the short and dysfunctional telomeres commonly found in these patients' cells (Armanios and Blackburn, 2012) . Heterozygous mutations of TERT and TERC represent major mutations in genetically defined telomere syndromes. Mutations of telomerase components are also associated with decreased fertility in both animals and humans (Herrera et al., 1999; Yan et al., 2014) .
Stem cell failure in highly proliferative tissues, such as hematopoietic stem cells, due to progressive telomere loss caused by insufficient telomerase activity is considered as an important therapeutic target for telomere syndromes (Armanios and Blackburn, 2012) . Indeed, allogeneic stem cell transplantation can reverse the aplastic anemia phenotype (Armanios and Blackburn, 2012; Young et al., 2006) . However, it has been a challenge to establish patient-specific induced pluripotent stem (iPS) cells with proper restoration of telomere defects using donor cells from patients with telomere syndrome (Batista et al., 2011; Winkler et al., 2013) .
Efficient generation of human pluripotent embryonic stem cells (ntESCs) with somatic cell nuclear transfer (SCNT) using oocyte factors represents a major advancement toward the realization of patient-specific cell therapies (Chung et al., 2014; Tachibana et al., 2013; Yamada et al., 2014) . Mouse ntESCs are transcriptionally and functionally indistinguishable from ESCs generated from fertilized embryos (Brambrink et al., 2006; Wakayama et al., 2001) . Human ntESCs also closely resemble ESCs (Chung et al., 2014; Tachibana et al., 2013) . Moreover, mice can be recloned by SCNT for more than 25 generations, without accumulation of errors, and show proper telomere maintenance (Wakayama et al., 2013) . Earlier this year, Le et al. (2014) reported that telomeres in Terc null mouse cells were reprogrammed after SCNT; however, they did not investigate whether, and to what extent, the telomeres of telomerase haplo-insufficient cells, which represents the majority of genotype-defined telomere syndrome patients, can be regenerated in ntESCs. The developmental pluripotency of telomerase insufficient ntESCs also remains to be determined. We performed experiments in order to test whether naive pluripotent stem cells with robust telomere elongation can be derived via SCNT from telomerase defective donor cells, using donor cells from Terc +/À mice in comparison with G2 Terc À/À mice. Figure S1A ). BLs of different Terc genotypes are morphologically indistinguishable ( Figure 1A) .
RESULTS

Development of Cloned Embryos
We next mechanically dissected the inner cell mass from these cloned embryos and plated them on feeder cells to derive ntESCs. The efficiencies of ntESC derivation were similar among three groups (WT: 17.4%; Terc
19.5%, Figure S1B ). These ntESC lines ( Figure 1B ) showed characteristics typical of mouse ESC markers (Oct4, Nanog, Sox2, and SSEA1) by immunofluorescence microscopy (Figure S1D ), expressed pluripotent genes as measured by RT-PCR (Oct4, Sox2, Nanog, and Rex1; Figure S1E ), and maintained normal karyotypes (66.6%-86.7%), regardless of their genotypes ( Figure S1C ). These results demonstrate that telomerase deficiency does not significantly compromise the in vitro development of cloned embryos and the derivation of ntESC lines.
Telomerase Haplo-Insufficient ntESCs Show Naive Pluripotency Previously, we established WT mouse ntESCs and demonstrated that they support full-term development by tetraploid embryo complementation (TEC) (Sung et al., 2010) , the most stringent test of naive pluripotency (Jaenisch and Young, 2008 Figure 1G ). Twenty-eight cloned Terc +/À ntESC pups were born, with a term-development rate of 7.6% ( Figures 1E and H), comparable to that of WT ntESCs (2%) (Sung et al., 2010) , and that of Terc +/À ESCs derived from normally fertilized embryos (9%) (Huang et al., 2011) . All Terc +/À pups showed C57BL/6 genetic background by microsatellite analysis, in contrast to the corresponding placentas with ICR background, confirming the clonal origin of the pups from the Terc +/À ntESCs ( Figure 1F ). However, 350 tetraploid embryos injected with Terc À/À ntESCs failed to produce any pups ( Figure 1E ), indicating significantly compromised in vivo pluripotency of Terc Huang et al., 2011) . These data show that telomerase haplo-insufficient ntESCs are capable of supporting full-term development, functionally validating their naive pluripotent state.
Robust Telomere Elongation in Telomerase Haplo-Insufficient ntESCs
Telomere lengths highly correlate with the developmental pluripotency of ESCs/iPSCs (Huang et al., 2011) . To determine whether telomere lengths are elongated in ntESCs with high developmental pluripotency, we measured relative telomere content/length (RTL) with qPCR, shown as relative telomere to single copy gene (T/S) ratio (Callicott and Womack, 2006 To validate the findings obtained by qPCR, we measured telomere lengths using Southern blot-based telomere restriction fragment (TRF) analysis ( Figure 2B ) (Blasco et al., 1997) . Consistent with the qPCR findings, telomeres were elongated robustly in WT, and also in Terc +/À , but not in Terc À/À ntESCs, compared with their donor cells. We also measured telomere length and function (telomere integrity and chromosome stability) of ntESCs by telomere quantitative fluorescent in situ hybridization (Q-FISH) ( Figure 2C ). Relative telomere lengths shown as telomere fluorescence intensities (telomere fluorescence unit, TFU) were shorter in TTFs of all three genotypes, but a correlation of the TFU with telomerase sufficiency was found with the TFU highest in WT (36.37 ± 13.75), followed by Figure 3A ). The clones were entirely derived from Terc +/À ntESCs of C57BL6 background with black coat color and confirmed by microsatellite genotyping, while the placentas were derived from WT tetraploid host embryo origin of ICR background.
RTLs of all clones measured (1.03-1.23) were similar to those of donor ntESCs (1.07 ± 0.07). RTLs of all placentas fell in a comparable range (1.07-1.19, Figure 3A ). These data show that fullterm clone pups from Terc +/À ntESC had telomere lengths like those of donor ntESCs. (the oldest of all) at newborn and at 4 months old and found no differences in telomere lengths among them, indicating that telomere lengths are properly maintained after birth and at least until 4 months of age ( Figure 3B ). Moreover, Clones 3 and 5 (male) were recently proven fertile. After breeding with WT females, they have fathered eight and six apparently normal pups, respectively (pups fathered by Clone 3 shown in Figure 1K ).
Complete Telomerase Deficiency Reduces Proliferation of ntESCs
Considering the fundamental roles of telomeres and telomerase in proliferation, we assessed proliferation rates of ntESCs with different levels of telomerase activity ( Figure S1F ). We seeded 100,000 cells on day 0 (D0) and counted the cell number on D2, D4, and D6. Number of cells on D6 was used as an indicator of cell proliferation rate. Terc À/À ntESCs, with shortest telomeres, turned out to proliferate at a much slower rate compared to Terc +/À and WT cells. Interestingly, Terc haplo-insufficient ntESCs proliferated at rates faster than WT ones. These data suggest that deficiency in self-renewal capacity may also contribute to the inability of Terc À/À ntESCs to support embryo generation by TEC assay, in addition to the compromised pluripotency.
Differential Expression of Genes Involved in Telomere Regulation
To gain insights into molecular differences in telomere lengths and pluripotency, we performed microarray of ntESCs with three genotypes using Illumina Mouse Ref-8 chips. One hundred nineteen genes of over 25,697 (0.46%) genes were differentially expressed at 2.0-fold or higher between the WT and Terc À/À ntESCs. Pairwise scatter plots ( Figure S3A ) suggest that expression of genes routinely used as markers of pluripotency, including Oct4, Nanog, Esrrb2, and Klf4, did not differ significantly among WT, Terc +/À , and Terc À/À ntESCs, consistent with data by immunostaining, RT-PCR (Figures S1D and S1E), and qPCR ( Figure S3B ). Our data support the notion that the conventional ES cell pluripotency markers cannot reliably distinguish ntESCs/ESCs with or without telomerase, nor can they indicate the naive developmental potency (Huang et al., 2011) . We also examined a number of genes related to telomere length regulation in the array data, followed by validation with qPCR. Probes for Terc were not in the array, unfortunately, but qPCR revealed that its expression was high in WT, moderate in Terc +/À , and undetectable in the Terc À/À cells, faithfully reflecting their corresponding genotypes ( Figure S3C ). Both array and qPCR showed that expressions of Tert, along with several other genes (i.e., Pot1a, Terf1, Terf2, Rtel1, Tep1, and Pinx1) did not differ among these ntESCs ( Figures S3A and S3C) . Notably, Zscan4, a key gene in telomerase-independent telomere elongation based on recombination (Zalzman et al., 2010) , was found differentially expressed in these ntESCs (Figure S3A ). Quantitative PCR ( Figure S3C ) and western blot (Figure S3D and Terc À/À TTFs and ntESCs using co-FISH (Wang et al., 2012) . Zscan4 expression levels of ntESCs of different Terc genotypes ( Figures S3C  and S3D ). To test whether Zscan4 is involved in maintaining telomeres of Terc À/À cells, we performed
Zscan4 knockdown experiments in Terc À/À ntESCs using two independent shRNA sequences, based on the methods described (Dan et al., 2014) . Indeed, Zscan4 knockdown resulted in telomere shortening in Terc À/À ntESCs ( Figures S3E-S3G ). These data suggest that telomerase deficiency and short telomeres eventually induce telomere recombination events, likely through activation of Zscan4, and that Zscan4 plays important roles in maintaining telomeres in telomerase-deficient cells.
DISCUSSION
We suggest that naive pluripotent patient-specific stem cells can be established with robust telomere regeneration from telomerase haplo-insufficient cells via SCNT. This may have implications for cell-based therapies for patients with telomere syndrome. Human iPSCs derived from cells with haplo-insufficient telomerase genes have so far failed to fully restore telomeres (Batista et al., 2011; Winkler et al., 2013) . Winkler et al. derived iPSCs from patients with aplastic anemia or hypocellular bone marrow carrying heterozygous mutations in TERT or TERC (Winkler et al., 2013) . The telomeres in these telomerase haploinsufficient iPSCs were elongated but at a lower extent comparing to the healthy iPSCs. Furthermore, these iPSCs showed defective hematopoietic differentiation in vitro (Winkler et al., 2013) . Consistently, we showed that iPSCs generated from telomerase haplo-insufficient isogenic mouse TTFs used in the present work also exhibit only limited telomere elongation and failure to produce complete iPSC pups (Wang et al., 2012) . Remarkably, telomeres of Terc +/À ntESCs are effectively elongated compared to the donor cells, and the Terc +/À ntESCs contribute to full-term development by TEC test, indicating naive pluripotency. Moreover, Terc +/À ntESC clones are fertile and do not show signs of premature aging, and their offspring appear normal. While reactivation of Terc may allow telomere elongation in telomerase defective iPSCs following prolonged passages (Agarwal et al., 2010) , SCNT-mediated telomere reprogramming of Terc haplo-insufficient cells does not appear to engage overactivation of Terc ( Figure S3C ). Instead, telomerase-independent mechanisms (Liu et al., 2007; Zalzman et al., 2010) may have contributed to the robust reprogramming of telomeres in Terc +/À ntESCs, which is supported by a recent report that telomeres of Terc À/À cloned blastocysts are longer than those of donor cells used for SCNT (Le et al., 2014) , as well as the present study. Previously we and others have shown that Zscan4 plays important roles in telomerase-independent mechanisms for iPSC reprogramming (Amano et al., 2013; Falco et al., 2007; Hirata et al., 2012; Jiang et al., 2013; Zalzman et al., 2010) . In the present work, we show that elevated Zscan4 levels are correlated with increased telomere recombination events in the Terc À/À ntESCs and that Zscan4 knockdown in these cells led to shortened telomeres, implicating the potential roles of Zscan4 in telomere maintenance of ntESCs. It is intriguing that the second generation or even third generation Terc À/À mice in our breeding colony, similar to those reported by others previously (Herrera et al., 1999) , are viable, whereas no viable pups generated from G2 Terc À/À ntESCs in the present work by TEC, and from conventional (i.e., derived from fertilized embryos) G1/3/4 Terc À/À ESCs in our earlier work (Huang et al., 2011 Figure 2D ), like those of Terc À/À ESCs (Huang et al., 2011) .
These defects of telomeres likely contribute to failure in embryonic development of G2 Terc À/À ntESCs in the present study, and of G1 and G3/4 Terc À/À ESCs in an earlier study (Huang et al., 2011) . Second, reduced cell proliferation of Terc
ntESCs is a factor. We show that complete telomerase deficiency reduces proliferation of ntESCs ( Figure S1F ), suggesting that deficiency in self-renewal capacity may also have contributed to the inability of Terc À/À ntESCs to support full-term development by TEC assay. Our work in chorus with several recent publications (Le et al., 2014; Li et al., 2014) arguably suggest that ntESCs appear to have certain advantages over their iPSC counterparts, and that at its minimum, researchers should aim to improve the iPSCs' quality to the level of ntESCs. In particular, SCNT may provide a strategy for correcting telomere deficiencies in patients with telomere syndrome. An early animal cloning study showed that telomere lengths of senescent somatic cells can be elongated by SCNT, even beyond those of newborns (Lanza et al., 2000) . Understanding SCNT-mediated telomere reprogramming would likely provide insights to improve iPSCs by identifying factors in oocytes to optimally reset telomeres. These ntESC lines are also valuable in vitro models to study telomere biology, especially considering the fact that stem cell failure is a common pathophysiological mechanism underling many of the telomere syndromes. , 1999; Huang et al., 2011) used in this work were at Generation 2 (G2).
EXPERIMENTAL PROCEDURES
SCNT, ntESC Derivation, and Tetraploid Embryo Complementation Assay SCNT was carried out using a previously described fusion method (Sung et al., 2010) . The spindle chromosome complex was removed using a pipette with an inner diameter of 8-10 mm assisted by piezo-drill pulses. Nuclei from donor cells were transferred by electrofusion to produce cloned embryos. When embryos reached the blastocyst stage after 4 days in culture, they were used to establish ES cell lines as we described previously (Sung et al., 2010) . In TEC assay, ICR strain mice were used to generate tetraploid blastocysts. For ESC injections, 10-15 ES cells were injected into one blastocyst using a flat tip pipette with an inner diameter of 14-16 mm assisted by piezo-drill pulses.
Tetraploid blastocysts containing injected ESCs were transferred to pseudopregnant recipient ICR females. The full-term pups were obtained from recipient mothers at day 18.5 by Caesarean section.
Telomere Measurements
Telomere lengths/contents were measured by qPCR (Callicott and Womack, 2006) , TRF analysis, and/or telomere Q-FISH. In qPCR, the telomere signal was normalized to the signal from the single-copy gene (36B4) to generate a T/S ratio indicative of relative telomere length of the given sample. The TRF analysis was performed using a commercial kit (TeloTAGGG Telomere Length Assay, catalog no. 12209136001, Roche Diagnostics). Telomere Q-FISH was used to estimate telomere length and function (telomere integrity and chromosome stability) as described previously (Huang et al., 2011; Wang et al., 2012) .
Statistical Analysis
Percentages were transformed with arcsin transformation. Percentage transformed data and other numbers were analyzed by ANOVA and means compared by Fisher's LSD using Graphpad Prism (v6.02, Graphpad Software). Significant differences were defined as p < 0.05 (*), 0.01 (**), and 0.001 (***).
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